Otonomy to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

Otonomy, Inc. (Nasdaq: OTIC) announced participation in three virtual conferences: a fireside chat at the Cowen 41st Annual Health Care Conference on March 4, 2021, at 12:50 p.m. ET, a pre-recorded presentation at the H.C. Wainwright Global Life Sciences Conference available on-demand starting March 9, 2021, and a presentation at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021, at 11:20 a.m. ET. Live audio webcasts will be accessible through the company's website.

Otonomy focuses on innovative therapeutics for neurotology, addressing conditions like Ménière’s disease and tinnitus.

SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management will participate in three upcoming virtual conferences:

• A fireside chat at the Cowen 41st Annual Health Care Conference on March 4, 2021 at 12:50 p.m. ET / 9:50 a.m. PT;
  
• A pre-recorded presentation at the H.C. Wainwright Global Life Sciences Conference available on-demand starting at 7 a.m. ET / 4 a.m. PT on March 9, 2021; and
  
• A presentation at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 at 11:20 a.m. ET / 8:20 a.m. PT.
  

Live audio webcasts will be available through the Events page of the company's website (www.otonomy.com).

About Otonomy

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus. For additional information, please visit www.otonomy.com.

Contacts:

Media Inquiries
Spectrum Science
Chloé-Anne Ramsey
Vice President
404.865.3601
cramsey@spectrumscience.com

Investor Inquiries
Westwicke ICR
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com

FAQ

What events is Otonomy participating in March 2021?

Otonomy will participate in three conferences: Cowen 41st Annual Health Care Conference on March 4, H.C. Wainwright Global Life Sciences Conference on March 9, and Oppenheimer 31st Annual Healthcare Conference on March 16, 2021.

When is the Otonomy fireside chat scheduled?

The Otonomy fireside chat is scheduled for March 4, 2021, at 12:50 p.m. ET.

How can I listen to Otonomy's conference presentations?

Live audio webcasts of Otonomy's conference presentations will be available through the Events page of their website.

What does Otonomy specialize in?

Otonomy specializes in the development of innovative therapeutics for neurotology, including treatments for Ménière’s disease, hearing loss, and tinnitus.

What is the date for Otonomy's presentation at the Oppenheimer Conference?

Otonomy's presentation at the Oppenheimer 31st Annual Healthcare Conference is on March 16, 2021, at 11:20 a.m. ET.